?:authorAffiliation
|
-
[\'Management of primary health care centers, Area I, Area II, Area III and Area IV, Servicio Cantabro de Salud, C. Vargas 57, 39010, Santander, Cantabria, Spain.\', \'Marqués de Valdecilla Research Institute (IDIVAL), s/n, Calle Cardenal Herrera Oria, 39012, Santander, Cantabria, Spain. lucialavinalconero@gmail.com.\', \'Clinical Trials Agency Valdecilla-IDIVAL, Marqués de Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain. lucialavinalconero@gmail.com.\', \'Marqués de Valdecilla Research Institute (IDIVAL), s/n, Calle Cardenal Herrera Oria, 39012, Santander, Cantabria, Spain.\', \'Department of Microbiology, Marqués de Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain.\', \'Department of Infectious Diseases, Marqués de Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain.\', \'Department of Community Health, Servicio Cantabro de Salud, C. Luis Vicente de Velasco 1, 39011, Santander, Cantabria, Spain.\', \'Emeritus Doctor, Department of Hematology, Marqués de Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain.\', \'Clinical Trials Agency Valdecilla-IDIVAL, Marqués de Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain.\', \'Department of Clinical Pharmacology, Marqués de Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain.\']
|